Menu Search
Equities

Diamond Biofund Inc

6901:TAI

Diamond Biofund Inc

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (TWD)39.60
  • Today's Change0.40 / 1.02%
  • Shares traded580.76k
  • 1 Year change-12.00%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in TWDView more

In 2023, Diamond Biofund Inc increased its cash reserves by 529.93%, or 1.77bn. Cash Flow from Financing totalled 4.36bn or -178.86% of revenues. In addition the company used 2.57bn for operations while cash used for investing totalled 26.60m.
Cash flow per share-2.46
Price/Cash flow per share--
Book value per share14.03
Tangible book value per share14.03
More ▼

Balance sheet in TWDView more

Diamond Biofund Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio104.24
Quick ratio--
Total debt/total equity0.0109
Total debt/total capital0.0107
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.